Pantazis-Michael Fotios Voutsinas

Dedicated and detail-oriented Infection consultant on immunocompromised patients due to bone marrow transplantation (BMT) or kidney transplantation with rare fungal infections and multi-drug resistant bacteria

European Resuscitation Council – ERC qualification, Advanced Life Support (ALS) 13/04/2019
14th School of Clinical Hepatology of the Hellenic Society for the Study of the Liver 2020-2021
ICH GOOD CLINICAL PRACTICE E6 (R2) 25/05/2020, 11/06/2021, 13/02/2023

• Antoniadou F, Dimitrakopoulou A, Voutsinas PM, Vrettou K, Vlahadami I, Voulgarelis M, Korkolopoulou P, Kafasi N, Mikou P.

Monomorphic epitheliotropic intestinal T-cell lymphoma in pleural effusion: A case report.

Diagn Cytopathol. 2017 Nov;45(11):1050-1054.

• Tsiakos K, Tsakiris A, Tsibris G, Voutsinas PM, Panagopoulos P, Kosmidou M, et al.

Early Start of Oral Clarithromycin Is Associated with Better Outcome in COVID-19 of Moderate Severity: The ACHIEVE Open-Label Single-Arm Trial.

Infect Dis Ther. 2021 Dec;10(4):2333-2351.

• Georgakopoulou VE, Vlachogiannis NI, Basoulis D, Eliadi I, Georgiopoulos G, Karamanakos G, Makrodimitri S, Samara S, Triantafyllou M, Voutsinas PM, Ntziora F, Psichogiou M, Samarkos M, Sfikakis PP, Sipsas NV.

A Simple Prognostic Score for Critical COVID-19 Derived from Patients without Comorbidities Performs Well in Unselected Patients.

J Clin Med. 2022 Mar 25;11(7):1810.

• Georgakopoulou VE, Makrodimitri S, Triantafyllou M, Samara S, Voutsinas PM, Anastasopoulou A, Papageorgiou CV, Spandidos DA, Gkoufa A, Papalexis P, Xenou E, Chelidonis G, Sklapani P, Trakas N, Sipsas NV.

Immature granulocytes: Innovative biomarker for SARS‑CoV‑2 infection.

Mol Med Rep. 2022 Jul;26(1):217.

• Georgakopoulou VE, Bali T, Adamantou M, Asimakopoulou S, Makrodimitri S, Samara S, Triantafyllou M, Voutsinas PM, Eliadi I, Karamanakos G, Basoulis D, Chatzipanagiotou O, Adamopoulou E, Alevizou A, Athanasiadis M, Spandidos DA, Papalexis P, Tarantinos K, Sipsas NV, Samarkos M, Cholongitas E.

Acute hepatitis and liver injury in hospitalized patients with COVID‑19 infection.

Exp Ther Med. 2022 Sep 26;24(5):691.

• Georgakopoulou VE, Basoulis D, Voutsinas PM, Papageorgiou CV, Eliadi I, Karamanakos G, Spandidos DA, Mathioudakis N, Papalexis P, Papadakos S, Fotakopoulos G, Tarantinos K, Sipsas NV.

Biomarkers predicting the 30‑day mortality of patients who underwent elective surgery and were infected with SARS‑CoV‑2 during the post‑operative period: A retrospective study.

Exp Ther Med. 2022 Sep 27;24(5):693.

• Georgakopoulou VE, Basoulis D, Voutsinas PM, Makrodimitri S, Samara S, Triantafyllou M, Eliadi I, Karamanakos G, Papageorgiou CV, Anastasopoulou A, Bitsani A, Kampouropoulou O, Eleftheriadou I, Gkoufa A, Spandidos DA, Papalexis P, Sipsas NV.

Factors predicting poor outcomes of patients treated with tocilizumab for COVID‑19‑associated pneumonia: A retrospective study.

Exp Ther Med. 2022 Oct 20;24(6):724

• Basoulis D, Avramopoulos P, Aggelara M, Karamanakos G, Voutsinas PM, Karapanou A, Psichogiou M, Samarkos M, Ntziora F, Sipsas NV.

Validation of Sequential ROX-Index Score Beyond 12 Hours in Predicting Treatment Failure and Mortality in COVID-19 Patients Receiving Oxygen via High-Flow Nasal Cannula.

Can Respir J. 2023 Feb 8;2023:7474564.

• Basoulis D, Mastrogianni E, Voutsinas PM, Psichogiou M.

HIV and COVID-19 Co-Infection: Epidemiology, Clinical Characteristics, and Treatment.

Viruses. 2023 Feb 20;15(2):577.

• Georgakopoulou VE, Gkoufa A, Tsakanikas A, Makrodimitri S, Karamanakos G, Basoulis D, Voutsinas PM, Eliadi I, Bougea A, Spandidos DA, Angelopoulou E, Steiropoulos P, Sipsas NV.

Predictors of COVID‑19‑associated mortality among hospitalized elderly patients with dementia.

Exp Ther Med. 2023 Jul 3;26(2):395.

• Basoulis D, Tsakanikas A, Gkoufa A, Bitsani A, Karamanakos G, Mastrogianni E, Georgakopoulou VE, Makrodimitri S, Voutsinas PM, Lamprou P, Kontos A, Tsiakas S, Gamaletsou MN, Marinaki S, Sipsas NV.

Effectiveness of Oral Nirmatrelvir/Ritonavir vs. Intravenous Three-Day Remdesivir in Preventing Progression to Severe COVID-19: A Single-Center, Prospective, Comparative, Real-Life Study.

Viruses. 2023 Jul 7;15(7):1515.

• Georgakopoulou VE, Gkoufa A, Makrodimitri S, Basoulis D, Tsakanikas A, Karamanakos G, Mastrogianni E, Voutsinas PM, Spandidos DA, Papageorgiou CV, Gamaletsou MN, Sipsas NV.

Early 3‑day course of remdesivir for the prevention of the progression to severe COVID‑19 in the elderly: A single‑centre, real‑life cohort study. 

Exp Ther Med. 2023 Aug 9;26(4):462.

• Georgakopoulou VE, Gkoufa A, Makrodimitri S, Tsakanikas A, Basoulis D, Voutsinas PM, Karamanakos G, Eliadi I, Samara S, Triantafyllou M, Eleftheriadou I, Kampouropoulou O, Papageorgiou CV, Anastasopoulou A, Papalexis P, Trakas I, Trakas N, Spandidos DA, Steiropoulos P, Sipsas NV.

Risk factors for the in‑hospital and 1‑year mortality of elderly patients hospitalized due to COVID‑19‑related pneumonia.

Exp Ther Med. 2023 Nov 20;27(1):22.

• Kaynote speaker in the 23rd National Conference on Infections Diseases in Greece on the subject of "Interesting clinical cases of infections" on the topic "General Hospital of Athens"Laiko": Recurrent and persistent pulmonary infiltrates of the right upper lobe", Athens, March 7-10, 2024
• Keynote speaker in the 22nd National Conference on Infectious Diseases in Greece on the subject of "Interesting clinical cases of infections" on the topic "General Hospital of Athens "Laiko": Multiple skin lesions and endophthalmitis in a patient with lymphoma and CAR T-cell therapy», Athens, March 2-5, 2023

• 11th INTERNATIONAL CONGRESS OF INTERNAL MEDICINE 2021 VALIDATION OF THE ROX-INDEX SCORE IN COVID-19 PATIENTS RECEIVING OXYGEN VIA HIGH FLOW NASAL CANNULA

Pantelis Avramopoulos, Maria Aggelara, Dimitris Basoulis, Georgios Karamanakos, Pantazis-Michalis Voutsinas, Amalia Karapanou, Mina Psichogiou, Michalis Samarkos, Nikolaos V Sipsas

• 31st ECCMID EUROPEAN CONGRESS OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES (9-12 JULY 2021)

4289. Community-acquired bacteraemia in very elderly patients: a prospective single-centre study

Pantazis-Michael Voutsinas, Nikos Zapaniotis, Angeliki Pantazatou, Ioannis Deliolanis, Nikolaos Sipsas, Maria Gamaletsou

• 2ndEDITION OF INTERNATIONAL VACCINES CONGRESS 2022

Factors predicting poor outcomes of patients treated with tocilizumab for COVID-19 pneumonia: A retrospective study

Vasiliki Epameinondas Georgakopoulou, Dimitrios Basoulis, Pantazis M. Voutsinas, Sotiria Makrodimitri, Stamatia Samara, Maria Triantafyllou, Irene Eliadi, Georgios Karamanakos, Chrysovalantis V. Papageorgiou, Amalia Anastasopoulou, Aikaterini Bitsani, Olga Kampouropoulou, Ioanna Eleftheriadou, Aikaterini Gkoufa, Demetrios A. Spandidos, Petros Papalexis, Nikolaos V Sipsas

• 25thInternational Symposium on Molecular Medicine 2023

Immature granulocytes: Innovative biomarker for SARS-CoV-2 infection

Vasiliki Epameinondas Georgakopoulou, Sotiria Makrodimitri, Maria Triantafyllou, Stamatia Samara, Pantazis M. Voutsinas, Amalia Anastasopoulou, Chrysovalantis V. Papageorgiou, Demetrios A. Spandidos, Aikaterini Gkoufa, Petros Papalexis, Euthalia Xenou, Georgios Chelidonis, Pagona Sklapani, Nikolaos Trakas, Nikolaos V. Sipsas

• 33rd ECCMID EUROPEAN CONGRESS OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (15-18 APRIL 2023)

P1159. Risk factors and outcomes of community-acquired bacteraemia: a prospective single centre study

Pantazis-Michael Voutsinas, Nikolaos Zapaniotis, Nikos Pantazis, Angeliki Pantazatou, Ioannis Deliolanis, Nikolaos V. Sipsas, Maria N. Gamaletsou

• 33rd ECCMID EUROPEAN CONGRESS OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (15-18 APRIL 2023)

P0741. Active surveillance for hospital-acquired infections due to multidrug resistant organisms in a hospital of a high-prevalence area, during the Omicron wave

Sofia Zerva, Amalia Karapanou, Ioannis Deliolanis, Antonis Markogiannakis,

Fotinie Ntziora, Amalia Anastasopoulou, Ioannis Pavleas, Maria N. Gkamaletsou, Dimitris Basoulis, Pantazis M. Voutsinas, Athanasios Kakasis, Elpida Mastrogianni, Flora Kontopidou, Michael Samarkos, George L. Daikos, Nikolaos V. Sipsas on behalf of the REVERSE study group

• 33rd ECCMID EUROPEAN CONGRESS OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (15-18 APRIL 2023)

P2495. Long-term infectious complications of tocilizumab administered for critical COVID-19 infection

Basoulis Dimitrios, Eirini Modestou, Markos Patsouras, Irene Eliadi, Pantazis-Michail Voutsinas, Stamatia Samara, Georgios Karamanakos, Vasiliki Georgakopoulou, Sotiria Makrodimitri, Nikolaos Sipsas

• 33rd ECCMID EUROPEAN CONGRESS OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (15-18 APRIL 2023)

P2554. Safety and effectiveness of three-day remdesivir regimen to prevent progression to severe COVID-19: a single-centre, real-world study

Basoulis Dimitrios, Pantazis-Michail Voutsinas, Stamatia Samara, Irene Eliadi, Georgios Karamanakos, Aikaterini Bitsani, Amalia Karapanou, Vasiliki Georgakopoulou, Sotiria Makrodimitris, Nikolaos Sipsas

• 21st European Congress of Internal Medicine (ECIM) joint with the 12th International Congress of Internal Medicine (15-18 March, 2023, Athens, Greece)

199 - Submission No. 658 COVID-19 PATIENT PRESENTING WITH

DELIRIUM AND MEMORY DEFICITS

Markos Patsouras, Eirini Modestou, Pantazis-Michail Voutsinas, Dimitrios Basoulis

• 21st European Congress of Internal Medicine (ECIM) joint with the 12th International Congress of Internal Medicine (15-18 March, 2023, Athens, Greece)

200 - Submission No. 660 SAFETY AND EFFECTIVENESS OF THE MONOCLONAL ANTIBODY COMBINATION CASIRIVIMAB/IMDEVIMAB FOR SEVERE COVID-19 PREVENTION: SINGLE-CENTER EXPERIENCE

Dimitrios Basoulis, Stamatia Samara, Aikaterini Bitsani, Pantazis-

Michail Voutsinas, Irene Eliadi, George Karamanakos, Amalia

Karapanou, Vasiliki Georgakopoulou, Sotiria Makrodimitri, Nikolaos Sipsas

• 21st European Congress of Internal Medicine (ECIM) joint with the 12th International Congress of Internal Medicine (15-18 March, 2023, Athens, Greece)

581 - Submission No. 665 EMPIRIC ANTIMICROBIAL USE IN A COVID-19 UNIT

Dimitrios Basoulis, Pantazis-Michail Voutsinas, Irene Eliadi, Stamatia Samara, George Karamanakos, Maria Triantafyllou, Vasiliki Georgakopoulou, Sotiria Makrodimitri, Antonis Markogiannakis, Michael Samarkos, Nikolaos Sipsas

• 5th Greco-Israeli Hematology Meeting (May 18th - 20th 2023, Thessaloniki, Greece)

P16. DIFFUSED CUTANEOUS FUSARIOSIS AND ASPERGILLUS ENDOPHTHALMITIS IN A PATIENT WITH R/R DLBCL POST CAR T-CELL THERAPY

Voutsinas P., Tsaprouni K., Anastasopoulou A., Tsifi A., Lefaki M., Petsa P., Benekou K., Apostolou O., Pantazatou A., Siasou G., Georgalas I., Angelopoulou M., Gamaletsou M.

Participated in 31 posted announcements (first author in 8 of them)

Taking part in sports (soccer)

Long distance running

Playing music (cornet, guitar)